The past, present, and future of antibiotics

MA Cook, GD Wright - Science translational medicine, 2022 - science.org
Antibiotics have transformed modern medicine. They are essential for treating infectious
diseases and enable vital therapies and procedures. However, despite this success, their …

Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials

S Walesch, J Birkelbach, G Jézéquel, FPJ Haeckl… - EMBO …, 2023 - embopress.org
Antibacterial resistance is one of the greatest threats to human health. The development of
new therapeutics against bacterial pathogens has slowed drastically since the approvals of …

Alternative therapeutic strategies to treat antibiotic-resistant pathogens

CR MacNair, ST Rutherford, MW Tan - Nature Reviews Microbiology, 2024 - nature.com
Resistance threatens to render antibiotics—which are essential for modern medicine—
ineffective, thus posing a threat to human health. The discovery of novel classes of …

The case against antibiotics and for anti-virulence therapeutics

JA Hotinger, ST Morris, AE May - Microorganisms, 2021 - mdpi.com
Although antibiotics have been indispensable in the advancement of modern medicine,
there are downsides to their use. Growing resistance to broad-spectrum antibiotics is …

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an …

S Esposito, G Amirthalingam, M Bassetti… - Frontiers in …, 2023 - frontiersin.org
Monoclonal antibodies (mABs) are safe and effective proteins produced in laboratory that
may be used to target a single epitope of a highly conserved protein of a virus or a bacterial …

Molecular targets and strategies for inhibition of the bacterial type III secretion system (T3SS); inhibitors directly binding to T3SS components

JA Hotinger, HA Pendergrass, AE May - Biomolecules, 2021 - mdpi.com
The type III secretion system (T3SS) is a virulence apparatus used by many Gram-negative
pathogenic bacteria to cause infections. Pathogens utilizing a T3SS are responsible for …

Microbiome modulation as a novel strategy to treat and prevent respiratory infections

BC Mindt, A DiGiandomenico - Antibiotics, 2022 - mdpi.com
Acute and chronic lower airway disease still represent a major cause of morbidity and
mortality on a global scale. With the steady rise of multidrug-resistant respiratory pathogens …

Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials

MM Elmassry, JA Colmer-Hamood, J Kopel… - Microorganisms, 2023 - mdpi.com
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes high
morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including …

Engineering the supernatural: monoclonal antibodies for challenging infectious diseases

PS Grace, BM Gunn, LL Lu - Current Opinion in Biotechnology, 2022 - Elsevier
Highlights•Technology advances have enhanced development of monoclonal antibodies for
infectious diseases.•Antibodies function through the collaboration between Fab and Fc …

Immunization and Immunotherapy Approaches against Pseudomonas aeruginosa and Burkholderia cepacia Complex Infections

SA Sousa, AMM Seixas, JMM Marques, JH Leitão - Vaccines, 2021 - mdpi.com
Human infections caused by the opportunist pathogens Burkholderia cepacia complex and
Pseudomonas aeruginosa are of particular concern due to their severity, their multiple …